OR WAIT null SECS
June 08, 2022
The acquisition grants Bristol Myers Squibb access to the company's oncology pipeline and lead candidate, repotrectinib.
June 03, 2022
Astellas and GO Therapeutics will work together to develop novel antibodies for immuno-oncology.
Thermo Fisher Scientific and Qatar Genome Program will use custom genotyping arrays to accelerate genomic research in Qatar.
June 01, 2022
GSK’s acquisition of Affinivax will give the company access to their portfolio of next-generation pneumococcal vaccines.
Agenus has entered into three new deals with Targovax, Oxford BioTherapeutics, and Immunogenesis, respectively, doubling its current number of clinical collaborations.
May 31, 2022
Through the Thermo Fisher Scientific and LabShares Newton partnership, life science startups can accelerate early-stage discovery and development with shared lab spaces.
Eurofins partners with PAMM to strengthen laboratory services for the Dutch healthcare system.
May 27, 2022
Biograd Diagnostics has chosen the Matrix Gemini system by Autoscribe Informatics as its laboratory information management system for managing COVID-19 test samples.
May 26, 2022
Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.
May 24, 2022
AbbVie and Cugene have reached an exclusive license option agreement for CUG252, Cugene’s lead therapeutic candidate.